Similar companies
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 1.85B | 1.1% |
| Gross Profit | 604M | 9% |
| Cost of Revenue | 1.25B | 2.3% |
| Operating expense | 374M | 2.5% |
| Net Income | 115M | 23.7% |
| EBITDA | 387M | 7% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 12.3B | 0.9% |
| Total Liabilities | 5.88B | 3.7% |
| Total Equity | 6.13B | 2% |
| Shares Outstanding | 1.29B | 0.1% |
Cash Flow (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 308M | 14.5% |
| Cash from investing | -178M | 16% |
| Cash from financing | -353M | 278.3% |
EPS
Financial Highlights for ICL Israel Chemicals in Q3 '25
ICL Israel Chemicals reported a revenue of 1.85B, which is a 1.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 604M, marking a 9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.25B, a -2.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 374M, showing a 2.5% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 115M, showing a 23.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 387M, showing a -7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for ICL Israel Chemicals with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
